4//SEC Filing
THORNTON NICHOLAS J 4
Accession 0001209191-04-049228
CIK 0001169358other
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 4:29 PM ET
Size
14.3 KB
Accession
0001209191-04-049228
Insider Transaction Report
Form 4
THORNTON NICHOLAS J
Group Executive Vice President
Transactions
- Disposition from Tender
Option to Purchase Common Stock
2004-10-20−35,000→ 0 totalExercise: $23.64From: 2004-10-20Exp: 2014-01-30→ Common Stock (35,000 underlying) - Disposition from Tender
Option to Purchase Common Stock
2004-10-20−15,000→ 0 totalExercise: $17.75From: 2004-10-20Exp: 2013-06-28→ Common Stock (15,000 underlying) - Disposition from Tender
Common Stock
2004-10-20−127,610→ 0 total(indirect: By Trust) - Disposition from Tender
Option to Purchase Common Stock
2004-10-20−20,000→ 0 totalExercise: $14.68From: 2004-10-20Exp: 2013-04-29→ Common Stock (20,000 underlying)
Footnotes (6)
- [F1]Rathbone Jersey Limited, as Trustee for the Thornton Trust, received a combination of cash and Charles River stock in exchange for the Trust's Inveresk common stock pursuant to the Agreement and Plan of Merger dated as of June 30, 2004, by and among the Issuer, Charles River Laboratories International, Inc., Indigo Merger I Corp. and Indigo Merger II Corp.
- [F2]These options originally began vesting one third after one year after grant (or vested one third on April 29, 2004), the next third after two years from the date of grant and the final third after three years. However, full vesting was accelerated to October 20, 2004 pursuant to the terms of Nick Thornton's Change of Control Agreement.
- [F3]These options were originally exercisable through the date specified. However, pursuant to the terms of Inveresk's Amended and Restated 2002 Stock Option and Incentive Compensation Plan, Nick Thornton will only have until January 20th, 2005 to exercise the Charles River stock options he receives in exchange for his Inveresk stock options.
- [F4]Nick Thornton received Charles River stock options in exchange for his Inveresk stock options pursuant to the Agreement and Plan of Merger dated as of June 30, 2004, by and among the Issuer, Charles River Laboratories International, Inc., Indigo Merger I Corp. and Indigo Merger II Corp.
- [F5]The options originally began to vest one third after one year after grant (or one third on June 28, 2004), the next third after two years from the date of grant and the final third after three years. However, full vesting was accelerated to October 20, 2004 pursuant to the terms of Nick Thornton's Change of Control Agreement.
- [F6]The options originally were not due to begin vesting until 1/30/2005. However, full vesting was accelerated to October 20, 2004 pursuant to the terms of Nick Thornton's Change of Control Agreement.
Documents
Issuer
INVERESK RESEARCH GROUP INC
CIK 0001169358
Entity typeother
Related Parties
1- filerCIK 0001226494
Filing Metadata
- Form type
- 4
- Filed
- Oct 21, 8:00 PM ET
- Accepted
- Oct 22, 4:29 PM ET
- Size
- 14.3 KB